切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2025, Vol. 19 ›› Issue (03) : 337 -340. doi: 10.3877/cma.j.issn.1674-3946.2025.03.028.

论著

甲状腺乳头状癌对侧中央区淋巴结转移的危险因素分析及预测模型构建
朱宗恒1, 张志火2,()   
  1. 1. 435000 湖北黄石,黄石市第四医院普外科
    2. 435000 湖北黄石,黄石市中心医院(湖北理工学院附属医院)普通外科
  • 收稿日期:2024-06-08 出版日期:2025-06-26
  • 通信作者: 张志火
  • 基金资助:
    湖北省2019年第一批联合基金立项项目(WJ2019H203)

Analysis of risk factors and construction of prediction model for contralateral central lymph node metastasis in papillary thyroid carcinoma

Zongheng Zhu1, Zhihuo Zhang2,()   

  1. 1. Department of General Surgery,the Fourth Hospital of Huangshi City,Huangshi Hubei Province 435000,China
    2. Department of General Surgery,Huangshi Central Hospital (Affiliated Hospital of Hubei Institute of Technology) ,Huangshi Hubei Province 435000,China
  • Received:2024-06-08 Published:2025-06-26
  • Corresponding author: Zhihuo Zhang
引用本文:

朱宗恒, 张志火. 甲状腺乳头状癌对侧中央区淋巴结转移的危险因素分析及预测模型构建[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(03): 337-340.

Zongheng Zhu, Zhihuo Zhang. Analysis of risk factors and construction of prediction model for contralateral central lymph node metastasis in papillary thyroid carcinoma[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(03): 337-340.

目的

分析甲状腺乳头状癌(PTC)对侧中央区淋巴结(Cont-CLNs)转移的危险因素,构建Cont-CLNs转移的预测模型,为PTC淋巴结清扫范围提供参考。

方法

回顾性选取116例接受甲状腺全切+双侧中央区淋巴结(CLNs)清扫术的PTC患者临床及超声资料。根据术后病理结果分为Cont-CLNs转移组和非转移组。数据分析采用SPSS 20.0软件处理,计数资料以[例(%)]表示,行χ2检验;二元Logistic回归分析Cont-CLNs转移的独立风险因素;构建Cont-CLNs转移的预测模型,采用ROC曲线、校准曲线及Hosmer-Lemeshow拟合优度检验评估该模型的诊断效能。P<0.05差异有统计学意义。

结果

116例PTC患者中有31例(26.7%)发生Cont-CLNs转移。Logistic回归分析显示,性别、肿瘤大小、包膜侵犯、患侧CLNs转移、颈中线淋巴结转移及微钙化是影响Cont-CLNs发生转移的独立风险因素(均P<0.05)。构建Cont-CLNs转移的回归预测模型,显示该模型预测Cont-CLNs转移的AUC值为0.816(0.697-0.902),拟合优度良好,预测值与实际值具有良好的一致性。

结论

男性、肿瘤≥2cm及发生包膜侵犯、患侧CLNs转移、颈中线淋巴结转移、微钙化是PTC患者发生Cont-CLNs转移的危险因素。

Objective

To analyze the risk factors for contralateral central lymph node (Cont-CLNs)metastasis in papillary thyroid carcinoma (PTC),construct a prediction model for Cont-CLNs metastasis,and provide a reference for the scope of lymph node dissection in PTC.

Methods

The clinical and ultrasound data of 116 PTC patients who underwent total thyroidectomy + bilateral central lymph node (CLNs) dissection were retrospectively selected.According to the postoperative pathological results,they were divided into the Cont-CLNs metastasis group and the non-metastasis group.The data were analyzed using SPSS 20.0 software.The counting data were expressed as [cases (%)] and the chi-square test was performed.Binary logistic regression was used to analyze the independent risk factors for Cont-CLNs metastasis.A prediction model for Cont-CLNs metastasis was constructed,and the receiver operating characteristic (ROC) curve,calibration curve,and Hosmer-Lemeshow goodness-of-fit test were used to evaluate the diagnostic efficacy of the model.A P value less than 0.05 was considered statistically significant.

Results

Among 116 PTC patients,31 cases (26.7%)had Cont-CLNs metastasis.Logistic regression analysis showed that gender,tumor size,capsular invasion,CLNs metastasis on the affected side,lymph node metastasis at the midline of the neck,and microcalcification were independent risk factors affecting Cont-CLNs metastasis (all P<0.05).A regression prediction model for Cont-CLNs metastasis was constructed,and it was shown that the area under the curve (AUC) value of this model for predicting Cont-CLNs metastasis was 0.816 (0.697-0.902),with good goodness-of-fit,and there was a good consistency between the predicted values and the actual values.

Conclusion

Male gender,tumor size≥2cm,capsular invasion,CLNs metastasis on the affected side,lymph node metastasis at the midline of the neck,and microcalcification are risk factors for Cont-CLNs metastasis in PTC patients.

表1 PTC患者Cont-CLNs转移单因素分析结果[例(%)]
项目 例数 Cont-CLNs转移(n=31) Cont-CLNs非转移(n=85) χ 2 P
年龄(岁) ≥45 41 13(41. 9) 28(32. 9) 0. 804 0. 370
<45 75 18(58. 1) 57(67. 1)
性别 30 14(45. 2) 16(18. 8) 8. 218 0. 004
86 17(54. 8) 69(81. 2)
肿瘤大小(cm) ≥2 24 11(35. 5) 13(15. 3) 5. 643 0. 018
<2 92 20(64. 5) 72(84. 7)
上极 71 13(41. 9) 58(68. 3) 6. 926 0. 031
肿瘤位置 中极 28 12(38. 7) 16(18. 8)
下极 17 6(19. 4) 11(12. 9)
病变腺叶 左叶 49 16(51. 6) 33(38. 8) 1. 523 0. 217
右叶 67 15(48. 4) 52(61. 2)
原发灶数目 单发 74 13(41. 9) 61(71. 8) 8. 751 0. 003
多发 42 18(58. 1) 24(28. 2)
包膜侵犯 31 18(58. 1) 13(15. 3) 21. 220 0. 000
85 13(41. 9) 72(84. 7)
患侧CLNs转移 阳性 61 23(74. 2) 38(44. 7) 7. 922 0. 005
阴性 55 8(25. 8) 47(55. 3)
合并HT 42 13(41. 9) 29(34. 1) 0. 601 0. 438
74 18(58. 1) 56(65. 9)
颈中线淋巴结转移 阳性 57 24(77. 4) 33(38. 8) 13. 539 0. 000
阴性 59 7(22. 6) 52(61. 2)
纵横比 >1 46 9(29. 0) 37(43. 5) 1. 995 0. 158
≤1 70 22(71. 0) 48(56. 5)
边界 清晰 32 7(22. 6) 25(29. 4) 0. 531 0. 466
不清晰 84 24(77. 4) 60(70. 6)
微钙化 62 24(77. 4) 38(44. 7) 9. 770 0. 002
54 7(22. 6) 47(55. 3)
回声 低回声 104 29(93. 5) 75(88. 2) 0. 691 0. 407
高/等回声 12 2(6. 5) 10(11. 8)
血流 34 12(38. 7) 22(25. 9) 1. 804 0. 179
82 19(61. 3) 63(74. 1)
表2 PTC患者 Cont-CLNs转移二元Logistic回归分析
图1 Cont-CLNs 转移预测模型评价 注: A为预测模型ROC曲线;B为预测模型校准曲线
[1]
Lam AK.Papillary Thyroid Carcinoma: Current Position in Epidemiology,Genomics,and Classification[J].Methods Mol Biol,2022,2534:1-15.
[2]
Mao J,Zhang Q,Zhang H,et al.Risk Factors for Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis[J].Front Endocrinol (Lausanne),2020,11:265.
[3]
吴元清,林杰,罗佳宝,等.甲状腺微小乳头状癌淋巴结转移和腺外侵犯的危险因素分析[J/CD].中华普外科手术学杂志(电子版),2021,15(03):319-322.
[4]
Du J,Yang Q,Sun Y,et al.Risk factors for central lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study[J].Front Endocrinol (Lausanne),2023,14:1288527.
[5]
中华人民共和国国家卫生健康委员会.甲状腺癌诊疗规范(2018年版)[J].中华普通外科学文献(电子版),2019,13(01):1-15.
[6]
李红强,马润声,唐艺峰,等.T1-2N0M0期甲状腺癌行全甲状腺切除加中央区淋巴结清扫必要性探讨[J].中国实用外科杂志,2021,41(08):892-894+899.
[7]
Zhou B,Qin JW.High-risk factors for lymph node metastasis incontralateral central compartment in unilateral papillary thyroidcarcinoma(cT1N0[)J].Eur J Surg Oncol,2021,47(4):882-887.
[8]
蒋安科,鄢传经.甲状腺乳头状癌颈淋巴结跳跃性转移因素Logistic回归分析[J/CD].中华普外科手术学杂志(电子版),2019,13(02):180-182.
[9]
Li X,Zhang H,Zhou Y,et al.Risk factors for central lymph node metastasis in the cervical region in papillary thyroid carcinoma: a retrospective study[J].World J Surg Oncol,2021,19(1):138.
[10]
朱毅凡,洒娜,赵婉君,等.cN0级单侧甲状腺乳头状癌患者对侧气管旁淋巴结转移临床特征的Meta分析[J].中国耳鼻咽喉头颈外科,2024,31(03):197-204.
[11]
Zhou J,Li DX,Gao H,et al.Relationship between subgroups of central and lateral lymph node metastasis in clinically nodenegative papillary thyroid carcinoma[J].World J Clin Cases,2022,10(12):3709-3719.
[12]
袁欣越,姚瑶,程帅,等.单侧甲状腺乳头状癌对侧淋巴结转移高危因素的临床研究[J].中国癌症杂志,2023,33(06):619-628.
[13]
尹新璐,陈博婕,莫嘉寅,等.喉前淋巴结转移在甲状腺乳头状癌中的临床意义[J].肿瘤,2021,41(11):749-757
[14]
樊逸隽,杨枫,王玮,等.喉前淋巴结转移对甲状腺乳头状癌诊疗价值的研究进展[J].中华普通外科学文献(电子版),2023,17(04):306-310
[15]
Sun W,Zheng B,Wang Z,et al.Meta-analysis of risk factors for CCLNM in patients with unilateral cN0 PTC[J].Endocr Connect,2020,9(5):387-395.
[16]
Kim DH,Kim SW,Hwang SH.Predictive Value of Delphian Lymph Node Metastasis in the Thyroid Cance[rJ].Laryngoscope,2021,131(9):1990-1996.
[17]
Chen ML,Xu D,Yan XQ,et al.Delphian lymph node metastasis predicts occult contralateral carcinoma for unilateral papillary thyroid carcinoma patients with contralateral benign nodules[J].Asian J Surg,2023,46(1):156-159
[18]
Luo X,Wang J,Xu M,et al.Risk model and risk stratification to preoperatively predict central lymph node metastasis in papillary thyroid carcinoma[J].Gland Surg,2020,9(2):300-310.
[19]
程剑峰,周琰,汤铖,等.单侧甲状腺乳头状癌伴同侧颈侧区淋巴结转移患者发生对侧中央区淋巴结转移的影响因素[J].中华老年多器官疾病杂志,2024,23(01):54-58.
[20]
Carolina W,Marisol G,Eleonora H,et al.Thyroid microcalcifications in the absence of identifiable nodules and their associationwith thyroid cancer [J].JUltras Med,2019,38(1):97-102.
[1] 王昕玥, 袁亚, 束华, 曹琨芃, 叶新华, 李璐. 基于LightGBM 算法构建超声引导下凝血酶治疗假性动脉瘤剂量预测模型[J/OL]. 中华医学超声杂志(电子版), 2025, 22(02): 153-161.
[2] 钱小梅, 罗洪, 李智慧, 周代君, 李东. 76例乙型肝炎肝硬化并发原发性肝癌的高危因素Logistic分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(03): 251-253.
[3] 袁强, 张华宇, 闫璋哲, 朱含放, 陈光, 孙亮, 吕远, 陈纲, 赵锁. cN0峡部偏侧甲状腺乳头状癌中央区淋巴结转移的术前预测模型[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(03): 333-336.
[4] 吉林霞, 范小春, 梁琴. 胃癌常见术后并发症类型及危险因素研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 220-223.
[5] 杨培容, 潘刚, 周春霞. 胰腺癌术后胰瘘的危险因素及治疗进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 228-230.
[6] 奚玲, 仝瀚文, 缪骥, 毛永欢, 沈晓菲, 杜峻峰, 刘晔. 基于肌少症构建的造口旁疝危险因素预测模型[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 48-51.
[7] 林宇腾, 延敏博, 许家榕, 黄子豪, 汤育新. 输尿管软镜手术术后住院时间的影响因素分析[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 41-46.
[8] 张红鹤, 杜亚君, 严华艳, 胡艳萍, 杨春旭, 王倩. 食管裂孔疝发生的危险因素分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2025, 19(01): 92-95.
[9] 李华志, 许臣, 吴永哲. 老年患者经腹腹膜前疝修补术后发生并发症的危险因素分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2025, 19(01): 96-98.
[10] 韩金昕, 刘阳, 熊振, 励超, 李嘉良, 王征, 蔡开琳, 王国斌, 陶凯雄, 蔡明. 营养状态对腹腔镜胃癌围手术期静脉血栓栓塞症的影响[J/OL]. 中华腔镜外科杂志(电子版), 2025, 18(01): 19-24.
[11] 余承澍, 刘红枝, 林科灿, 林起柱, 黄霆峰, 周伟平, 程张军, 楼健颖, 郑树国, 毕新宇, 王剑明, 郭伟, 李富宇, 王坚, 郑亚民, 李敬东, 程石, 曾永毅. 肝内胆管细胞癌术后极早期复发的危险因素[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 53-59.
[12] 李鑫, 李乐, 陈金明, 刘蕊. 基于Meta 分析构建肝癌微血管侵犯的术前预测模型[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 74-80.
[13] 任船, 葛荣忠, 邱正才, 朱莉. 肠癌患者术后代谢性酸中毒的预测模型构建及应用价值评价[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(01): 34-39.
[14] 段红良, 赵红梅, 李涛, 辛建锋. 结直肠癌组织SPOCD1表达与临床病理特征及术后复发转移的关系[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(01): 40-45.
[15] 文杨, 刘健, 姚海波, 金梅, 杨胜, 马荣川. 超声心动图联合实验室检查预测静脉注射丙种球蛋白无反应性川崎病的价值[J/OL]. 中华诊断学电子杂志, 2025, 13(01): 51-58.
阅读次数
全文


摘要